Dermatologic Pharmaceuticals | Pharm 2 | Chapter 17 | Questions and Answers

012345689342 012342921







!"#!$%!&'!'()*'#+),!-"./0).,!12""*!3',,'2,%4!56789:
;<
=7<<>
?988978
@;<AB
?68CD76EF

G
H0+'!/&'!I!20J'#,!"K!LM).!K#"+!,N('#K)-)02!/"!*''(%4!OPQ>9ERQ8B
S9ERQ8B
TD=U
@VWP<>9ERQ8F

X
Y&0/!20J'#!"K!/&'!,M).!-"./0).,!12""*!3',,'2,Z!2J+(&Z!0.*!.'#3',[4!S9ERQ8

\
Y&0/!20J'#!"K!,M).!-"./0).,!2"",'!/),,N'Z!K0/Z!0.*!-"..'-/)3'!/),,N'[4!TD=U
@VWP<>9ERQ8F

]
^._)"_'.',),4!`a9
>9?97<PR9Ab
<c
=7<<>
?988978

d
eef4!^.!0_'./!/&0/!-0N,',!-"./#0-/)".!0K/'#!0((2)-0/)".!/"!0!/),,N'%4!g8bEQAB
h9Ab

i(#'
Y& 0/!),!/'#+'*!/&'!&J('#/#"(&J!"K!/&'!&"#.J!20J'#!"K!/&'!'()*'#+),!).!0!2"-02)j'*!0#'0!0,!0!#',N2/!"K!
,,N#'!"#!K#)-/)".[4!k677D8
@9l:
O7=<m
C677D8F

n
ee4!0!(2N_!"K!M'#0/).!0.*!,'1N+!o)/&).!0!&0)#!K"22)-2'!"K!/&'!,M).!p120-Mf!&'0*q%4!k<R9><A98

r
s'#+0/)/),4!tAc76RR6bQ<A
<c
ba9
87QA


u
v#J/&'+04!w9>A988
<c
ba9
8xQA




vyN*0/)".4!z96x6h9
<c
c7DQ>{
C9778{
<E
C977D76E
>9=EQ8
c<ER
=7<<>
?988978
6A>
ba9QE
>9P<8QbQ<A
QA
ba9
bQ88D9


bQ8G8D9
Y& 0/!),!|#0.N20/)".!/),,N'[4!;9m
bQ88D9
c<ER9>
QA
ba9
a967QAh
m<DA>8
<c
ba9
8<cb
bQ88D9{
C<A8Q8bQAh
<c
C<AA9CbQ?9


C9778
6A>
QAhE<mA
W<DAh
?98897
@D7bQR6b97W
c<ER8
6
8C6EF


X
&'!)./'_N+'./0#J!,J,/'+!),!('#/0).)._!/"!o&0/!1"*J!(0#/[4!TxQA


\
ee4!^.!0_'./!/&0/!(#"+"/',!2"",'.)._!"#!,'(0#0/)".!"K!/&'!&"#.J!20J'#!"K!/&'!'()*'#+),%4!}9E6b<7WbQC


4!}9 ]E
6ee4 !^.!0_'./!/&0/!(#"+"/',!."#+02)j0/)".!"K!/&'!*'3'2"(+'./!"K!M'#0/).%f!
b<P768bQC


d
~#N#)/N,4!tbCaQAh


i
Y&0/!),!0!~J"*'#+0[4!gAW
8xQA
>Q89689
ba6b
Q8
Ca6E6Cb9EQ9>
=W
ba9
PE989AC9
<c
PD8


n
Y&0/!),!L'1"##&'0[4!gA
QACE9689
8C67QAh
<c
ba9
8xQA€
89=DR
PE<>DCbQ<A
R6W
<E
R6W
A<b
QACE9689


ƒ:r
T9
=H0 +'!/&'!!M).*!"K!L'1"##&'04!‚:
T9=<EEa96
<79<86
@<Q7W
xQA>F

<EEa96
8QCC6
@>EW
xQA>F

G u
!"#!$%!L'1"##&'0!,)--0!),!0!-".*)/)".!-&0#0-/'#)j'*!1J!,-02)._!0.*!'y-',,!2)()*!(#"*N-/)".!/&0/!K"#+,!1#"o.),&!
J'22"o!-2N+(,Z!o&)-&!0*&'#',!/"!/&'!,M).!0.*!&0)#%4!56789:
T9=<EEa96
<79<86

G&0
)#%
4!`E !"#!$%!L'1"##&'0!,)--0!),!-&0#0-/'#)j'*!1J!*#J!,M).!0.*!o&)/'!/"!_#0J!,-02',!/&0/!*"!."/!0*&'#'!/"!/&'!,M).!"#!
D9:
TQCC6
Q8
>EW
xQA>:








,

012345689342 012342921








!"#$"%$&'#((#)*+,"),-."*&"/.0*++1.#"21#+#2).+%3.4"0,"/2#'%$5"#$4"5+.#/%$.//6!"789:;;<8=>
?8;@AB=B=C


O=DII

NE"88*?+
":F6;A"EI
*@8
-%2#'"(.4%2#)%*$/"2#$"0."G/.4")*")+.#)"4..-"-,*4.+(#/6!"HAIC8J
K88L
LM:?8;@AC
>AN
98
CMCB8@=>J

?=>AB=:NC
PB:L=>AIC
Q:;
CRL8;Q=S
>=AIT


K8U8L

V1 #)"2*$4%)%*$"%/"21#+#2).+%3.4"0,"#$"%$&.2)%*$"0.'*W")1.".-%4.+(%/X!"Y"
LM:?8;@A


Z
[..-"-,*4.+(#/"W%''"+.\G%+."#")+.#)(.$)"-.+%*4"*&" ])%(.^6!"_8`R=;8C
a
b88cC


B:dL=>
AV1
IT

#)"(.)1*4"*&"(.4%2#)%*$"#4(%$%/)+#)%*$"%/"-+.&.++.4")*")+.#)"4..-"-,*Y"4.+(#/X!"e;AI
ANB=9=:B=>C
PN:B


P9f8>A
V1 #)"(.)1*4"*&"(.4%2#)%*$"#4(%$%/)+#)%*$"%/"-+.&.++.4")*")+.#)"/G-.+&%2%#'"-,*4.+(#/X!"g:L=>AI
ANB=9=:B=>C

RC8
B<8M
?:
N:
L8N8B;AB8
98I:b
?8;@=C
IAM8;T


h
i$4"j"#2)%k."%$5+.4%.$)"4+G5/")1#)"#+."2*((*$',"G/.4"%$")*-%2#'/")*")+.#)"/G-.+&%2%#'"-,*4.+(#/6!"PS>=NT

l
mA>=B;A>=N

l
n8:@M>=N

l
o:IM@=p=N
m

l
q8NBA@M>=N

l
rRI=;:>=N


s
[.+(#)*(,2*/./!"_=Ntb:;@
PQRNtAI
=NQ8>B=:N
:Q
Cc=NT

Du
E"*+"F6"[.+(#)*(,2*/./"%/"3**$*)%26!"g;R8

Dv
w#(."j"2*((*$")*-%2#'"i$)%&G$5#'/"G/.4")*")+.#)"[.+(#)*(,2*/./6!"S
xI:B;=@Ay:I8

l
r=>:NAy:I8

l
nMCBAB=N

l
z=@8
CRIQ8;
K=L

l
x:LL8;
NAL<B<8NAB8
Pge{|x
ge
x}g7T

D

V1%21")*-%2#'"#$)%&G$5#'"4+G5"G/.4")*")+.#)"[.+(#)*(,2*/./"%/")*~%2")*"2#)/X!"x:LL8;
NAL<B<8NAB8

DD
w#(.""2*((*$"€€E‚ƒ„ "#$)%&G$5#'"4+G5/"G/.4")*")+.#)"[.+(#)*(,Y"2*/./6!"S
S
|B;A>:NAy:I8

l
†8B:>:NAy:I8

l‡
}I
HIR>:NAy:I8

I
A;8
m8Ny=@=?Ay:I8C
ANB=QRNtAIC‡

l
nMCBAB=N

l
g8;9=NAQ=N8

l
}@L<:B8;=>=N
m
PRC8?
=N
8@8;t8N>MT